EFFECTS OF RESERPINE PRE-TREATMENT ON THE PROTECTIVE ACTION OF AMPHETAMINE AND PHENOXYPROPAZINE IN THE PHENYLBENZOQUINONE-INDUCED WRITHING SYNDROME IN MICE.
D000661:Amphetamine; D000662:Amphetamines; D000818:Animals; D001522:Behavior, Animal; D016227:Benzoquinones; D006834:Hydrazines; D007545:Isoproterenol / Q000031:analogs & derivatives; D008238:Lysergic Acid Diethylamide; D051379:Mice; D008996:Monoamine Oxidase Inhibitors; D010600:Pharmacology; D012106:Research; D012110:Reserpine; D012701:Serotonin; D013565:Sympatholytics
D000662:Amphetamines; D016227:Benzoquinones; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D013565:Sympatholytics; D012701:Serotonin; C029322:phenylbenzoquinone; C084776:pheniprazine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D007545:Isoproterenol; C084581:dichloroisoproterenol
AMPHETAMINE; BEHAVIOR, ANIMAL; DICHLOROISOPROTERENOL; EXPERIMENTAL LAB STUDY; HYDRAZINES; LYSERGIC ACID DIETHYLAMIDE; MICE; MONOAMINE OXIDASE INHIBITORS; PHARMACOLOGY; PHENIPRAZINE; RESERPINE; SEROTONIN; SYMPATHOLYTICS